Sanofi News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

29.04.14	Sanofi Q1 Consolidated Profit Rises - Quick Facts (RTTNews)
28.04.14	Sanofi Pasteur's Phase III Trial With Dengue Vaccine Meets Primary Endpoint (RTTNews)
21.04.14	Aastrom Biosciences To Buy Sanofi's CTRM Business For $6.5 Mln - Quick Facts (RTTNews)
07.04.14	Sanofi Says Genzyme To Resubmit Lemtrada Application For FDA Review (RTTNews)
01.04.14	Sanofi Pasteur: FDA Expands Approved Age Indication Of Adacel - Quick Facts (RTTNews)
01.04.14	Sanofi, Regeneron Report Positive Results On Alirocumab Phase 2 Japanese Study (RTTNews)
31.03.14	Sanofi Appoints Anne Beal To Newly Created Role Of Chief Patient Officer (RTTNews)
21.03.14	Genzyme Gains Approval From Brazil For Monoclonal Antibody Lemtrada (RTTNews)
21.03.14	Genzyme’s Lemtrada™ Approved in Brazil for Treatment of Multiple Sclerosis (Businesswire)
28.02.14	Actavis Confirms Generic Multaq Patent Challenge By Sanofi - Quick Facts (RTTNews)
24.02.14	Ardelyx Licenses NaP2b Phosphate Inhibitor Program To Sanofi (RTTNews)
18.02.14	Sanofi Announces European Commission Approval For NexGard - Quick Facts (RTTNews)
06.02.14	Sanofi Q4 Profit Surges On Lower Costs (RTTNews)
06.02.14	Sanofi Q4 Profit Rises - Quick Facts (RTTNews)
06.02.14	Sanofi FY 2013 - Interview with CEO Chris Viehbacher (Businesswire)
31.01.14	Lilly Issues Statement On Sanofi U.S. Lawsuit (RTTNews)
31.01.14	Sanofi Files Patent Infrigement Suit Agains Eli Lilly (RTTNews)
13.01.14	Genzyme Expands Alliance With Alnylam Pharma, To Invest $700 Mln For 12% Stake (RTTNews)
13.01.14	Alnylam Pharma, Genzyme Form New RNAi Therapeutics Alliance - Quick Facts (RTTNews)
30.12.13	Genzyme Gets Complete Response Letter From FDA On Lemtrada Application (RTTNews)
19.12.13	Sanofi, Regeneron To Collaborate With ACC For PCSK9 Inhibitor Clinical Program (RTTNews)
13.12.13	Genzyme Says Health Canada Approves Lemtrada For Multiple Sclerosis (RTTNews)
12.12.13	Merial Granted EMA Approval For Broadline For Broad Spectrum Parasite Treatment (RTTNews)
03.12.13	Sanofi Reports Phase 3 Results For Investigational New Insulin U300 (RTTNews)
25.11.13	Alnylam Earns $7 Mln Milestone Payment From Genzyme On Patisiran Achievement (RTTNews)
24.11.13	Biogen Idec Gets Regulatory Protection For MS Drug Tecfidera In Europe (RTTNews)
22.11.13	Sanofi, Regeneron Report Positive Data With Sarilumab In Phase 3 Arthritis Trial (RTTNews)
22.11.13	Sanofi, Regeneron Report Positive Results With Sarilumab In First Phase 3 Trial (RTTNews)
21.11.13	Genzyme Convenes 5th Annual Gaucher Leadership Forum in Madrid (Businesswire)
18.11.13	Sanofi To Halt Clinical Trials Of JAK2 Inhibitor Fedratinib (RTTNews)
18.11.13	Sanofi Discontinues JAK2 Agent Fedratinib Clinical Trials - Quick Facts (RTTNews)
07.11.13	Sanofi Prices EUR 1 Bln Notes Due 2023 (RTTNews)
30.10.13	Sanofi Q3 Profit Down; Sees Annual EPS At Lower End Of Previous View (RTTNews)
30.10.13	Sanofi Q3 2013 - Interview with CFO Jérôme Contamine (Businesswire)
30.10.13	Sanofi Q3 Profit Drops - Quick Facts (RTTNews)
16.10.13	Sanofi, Regeneron Say Alirocumab Significantly Reduces Bad Cholesterol (RTTNews)
07.10.13	Sanofi CEO Expects Return To Growth In Q4 : Bloomberg (RTTNews)
03.10.13	Genzyme Announces Positive Data From TOPIC Study Of Once-daily, Oral Aubagio (RTTNews)
24.09.13	Sanofi Reports GetGoal-L Sub-analysis Results - Quick Facts (RTTNews)
24.09.13	Sanofi Reports FDA Approval For NexGard Chewables - Quick Facts (RTTNews)
17.09.13	European Commission OKs Genzyme's Multiple Sclerosis Treatment Lemtrada (RTTNews)
16.09.13	Sanofi Re-introduces Rolaids In U.S. - Quick Facts (RTTNews)
14.09.13	Sanofi Likely To Repurchase 9% Stake Of L'Oreal (RTTNews)
12.09.13	Sanofi To Withdraw Lixisenatide NDA In U.S. - Quick Facts (RTTNews)
04.09.13	Sanofi, POZEN Sign Deal For Commercialization Of PA8140/PA32540 Tablets In U.S. (RTTNews)
30.08.13	Genzyme Gets Marketing Authorization For Aubagio In Europe - Quick Facts (RTTNews)
29.08.13	Sanofi Prices EUR 1 Bln 2020 Bond Issue - Quick Facts (RTTNews)
26.08.13	Sanofi: Fluzone High-Dose Influenza Vaccine Efficacy Trial Meets Primary Goal (RTTNews)
26.08.13	Sanofi Pasteur Reports Topline Results Of Efficacy Trial Of Fluzone High-Dose (RTTNews)
06.08.13	HNSN Jumps 22%, MDCO Reaches FINISH Line, SNY's Shot At Superbug Vaccine (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

18:01		Verluste in New York: Dow Jones legt den Rückwärtsgang ein
18:01		Pluszeichen in New York: NASDAQ Composite mittags in Grün
18:01		Optimismus in New York: S&P 500 legt am Dienstagmittag zu
18:01		Optimismus in New York: NASDAQ 100 mittags freundlich
17:58		Schwache Performance in Europa: Euro STOXX 50 schlussendlich leichter

18:01

Verluste in New York: Dow Jones legt den Rückwärtsgang ein

18:01

Pluszeichen in New York: NASDAQ Composite mittags in Grün

18:01

Optimismus in New York: S&P 500 legt am Dienstagmittag zu

18:01

Optimismus in New York: NASDAQ 100 mittags freundlich

17:58

Schwache Performance in Europa: Euro STOXX 50 schlussendlich leichter